Abstract:Polyglucosan storage disorders represent an emerging field within neurodegenerative and neuromuscular conditions. We combined molecular genetic analyses, quantitative mass spectrometry of laser micro‐dissected polyglucosan bodies, immunohistochemistry and western blot, and show that the absence of glycogenin‐1 (GYG1), a protein important for glycogen synthesis initiation, causes storage of polyglucosan that displays accumulation of several proteins, including those essential for glycogen synthesis, sequestosome 1/p62 and desmin. Aims Polyglucosan storage disorders represent an emerging field within neurodegenerative and neuromuscular conditions, including Lafora disease (EPM2A, EPM2B), adult polyglucosan body disease (APBD, GBE1), polyglucosan body myopathies associated with RBCK1 deficiency (PGBM1, RBCK1) or glycogenin‐1 deficiency (PGBM2, GYG1). While the storage material primarily comprises glycans, this study aimed to gain deeper insights into the protein components by proteomic profiling of the storage material in glycogenin‐1 deficiency. Methods We employed molecular genetic analyses, quantitative mass spectrometry of laser micro‐dissected polyglucosan bodies and muscle homogenate, immunohistochemistry and western blot analyses in muscle tissue from a 45‐year‐old patient with proximal muscle weakness from late teenage years due to polyglucosan storage myopathy. Results The muscle tissue exhibited a complete absence of glycogenin‐1 due to a novel homozygous deep intronic variant in GYG1 (c.7+992T>G), introducing a pseudo‐exon causing frameshift and a premature stop codon. Accumulated proteins in the polyglucosan bodies constituted components of glycogen metabolism, protein quality control pathways and desmin. Muscle fibres containing polyglucosan bodies frequently exhibited depletion of normal glycogen. Conclusions The absence of glycogenin‐1, a protein important for glycogen synthesis initiation, causes storage of polyglucosan that displays accumulation of several proteins, including those essential for glycogen synthesis, sequestosome 1/p62 and desmin, mirroring findings in RBCK1 deficiency. These results suggest shared pathogenic pathways across different diseases exhibiting polyglucosan storage. Such insights have implications for therapy in these rare yet devastating and presently untreatable disorders.

Polyglucosan Body Myopathy 1 May Cause Cognitive Impairment: a Case Report from China.

A case of polyglucosan body myopathy caused by an RBCK1 gene variant and literature review

Phenotypic and genotyping spectrum of two Iranian cases with RBCK1‐associated polyglucosan body myopathy

A novel likely pathogenic homozygous RBCK1 variant in dilated cardiomyopathy with muscle weakness

Proteomic profiling of polyglucosan bodies associated with glycogenin‐1 deficiency in skeletal muscle

Congenital Disorder of Glycosylation Type 1T with a Novel Truncated Homozygous Mutation in PGM1 Gene and Literature Review.

Uniparental disomy for chromosome 1 with POMGNT1 splice-site variant causes muscle-eye-brain disease

[Clinical and Mutation Analysis of a Chinese Family with Muscle Eye Brain Disease].

Lysosomal degradation of GMPPB is associated with limb-girdle muscular dystrophy type 2T.

GMPPB-congenital Disorders of Glycosylation Associate with Decreased Enzymatic Activity of GMPPB

Identification and Pathogenicity Prediction of a Novel GLB1 Variant C.101t>c (p.ile34thr) in an Infant with GM1 Gangliosidosis

Novel POMGnT1 Mutations Cause Muscle-Eye-brain Disease in Chinese Patients

Case report: Comprehensive exploration of a novel PFKM mutation in glycogen storage disease Type VII

A Novel VCP Mutation As the Cause of Atypical IBMPFD in a Chinese Family.

Muscle pathology and whole-body MRI in a polyglucosan myopathy associated with a novel glycogenin-1 mutation

PSEN1 G417S Mutation in a Chinese Pedigree Causing Early-Onset Parkinsonism with Cognitive Impairment.

Novel Mutations in the C-terminal Region of GMPPB Causing Limb-Girdle Muscular Dystrophy Overlapping with Congenital Myasthenic Syndrome

Phenotype and Genotype Study of Chinese POMT2-Related α-Dystroglycanopathy

Clinical and Molecular Genetic Characterization of Two Patients with Mutations in the Phosphoglucomutase 1 (PGM1) Gene

Lipid-storage myopathy with glycogen storage disease gene mutations mimicking polymyositis: a case report and review of the literature

A Mild Clinical Phenotype with Myopathic and Hemolytic Forms of Phosphoglycerate Kinase Deficiency (PGK Osaka): A Case Report and Literature Review